Sernova Biotherapeutics (OTCMKTS:SEOVF) Posts Quarterly Earnings Results, Hits Estimates

Sernova Biotherapeutics (OTCMKTS:SEOVF) issued its quarterly earnings results on Thursday. The company reported ($0.01) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.01), Zacks reports.

Sernova Biotherapeutics Trading Up 3.8%

Shares of Sernova Biotherapeutics stock opened at $0.10 on Friday. The company’s 50-day moving average price is $0.08 and its two-hundred day moving average price is $0.10. The stock has a market cap of $38.52 million, a PE ratio of -2.55 and a beta of 0.86. Sernova Biotherapeutics has a 52 week low of $0.07 and a 52 week high of $0.14.

Sernova Biotherapeutics Company Profile

Sernova Biotherapeutics is a clinical‐stage biotechnology company focused on developing and commercializing cell‐based therapeutic technologies for patients with chronic and life‐threatening diseases. Headquartered in London, Ontario, Canada, the firm is advancing an implantable device platform designed to support the long-term survival and function of therapeutic cells. The company’s lead product candidate, known as the Cell Pouch System, is engineered to create a vascularized environment in which transplanted cells can thrive, with an initial emphasis on treating patients with type 1 diabetes.

In its core program, Sernova has initiated a Phase I/II clinical trial evaluating the safety and efficacy of the Cell Pouch System in individuals with type 1 diabetes who require islet cell transplantation.